HIPAA Alert: Potential Data Breach Learn More

Search
Close this search box.
Print Friendly, PDF & Email

NCT/Study#

NA /

NL-201-MM

Phase 1 IV-Infusion Study Of Our Investigational Drug, NL-201

DISEASE GROUP:
Multiple Myeloma
current phase:
Phase I
STUDY STATUS:
Active
Location:
Hackensack, NJ
For More information: